top of page

NEW Evidence in First-Line AML & Exploring Outcomes with Fixed-Duration Treatment for CLL

Thu, Nov 12

|

Webinar

Registration is Closed
See other events
NEW Evidence in First-Line AML & Exploring Outcomes with Fixed-Duration Treatment for CLL
NEW Evidence in First-Line AML & Exploring Outcomes with Fixed-Duration Treatment for CLL

Time & Location

Nov 12, 2020, 8:00 PM

Webinar

About The Event

BONS MEMBERS ONLY

Thursday, November 12, 2020, 8:00 PM ET

Vinod Pullarkat, MD Clinical Professor of Hematology & Hematopoietic Cell Transplantation City of Hope Comprehensive Cancer Center, Duarte, CA

Nakhle Saba, MD Associate Professor of Medicine, Section of Hematology and Medical Oncology Tulane University, New Orleans, LA

Follow this link to REGISTER!

https:// abbvie.meintl.com/00071-OB20-20

Share This Event

BONS logo.png

Contact:

Daunielle Ricardi, President

Alissa Gentile, Treasurer

Cameron Keith, Social Media Coordinator

Email: BonsSocialMedia@gmail.com

  • Facebook
  • Instagram
  • LinkedIn
Earthen Media-4.png
bottom of page